BACKGROUND: Only a few studies have investigated the prospective relationship between insulin-like growth factor binding protein-1 (IGFBP-1) and cardiovascular events and the results are conflicting. METHODS: In this prospective cohort study, we followed both cases, i.e. survivors of a first acute myocardial infarction (AMI) and their age, sex and hospital catchment area matched controls of a large population-based case-control study for 8 years for total and cardiac mortality, AMI, stroke and hospitalization for heart failure (HF). Levels of IGFBP-1 were measured three months after AMI in a stable metabolic phase in 853 patients. For 1106 control subjects, the time of measurement was as close as possible to that of 'his/her' case. Established cardiovascular risk and prognostic factors were also determined. RESULTS: Higher IGFBP-1 values predicted hospitalization for HF during follow-up both in the patient and the control cohort. Control subjects with higher IGFBP-1 values had elevated mortality when compared to those with the lowest quartile. The associations between IGFBP-1 and other outcomes investigated in this study, i.e. mortality among patients, AMI or stroke among patients and controls were weak and statistically not significant. CONCLUSIONS: Levels of IGFBP-1 consistently predicted HF both among survivors of a first AMI and their matched controls. Our results suggest that IGFBP-1 levels might also predict mortality in a population free of previous AMI.
BACKGROUND: Only a few studies have investigated the prospective relationship between insulin-like growth factor binding protein-1 (IGFBP-1) and cardiovascular events and the results are conflicting. METHODS: In this prospective cohort study, we followed both cases, i.e. survivors of a first acute myocardial infarction (AMI) and their age, sex and hospital catchment area matched controls of a large population-based case-control study for 8 years for total and cardiac mortality, AMI, stroke and hospitalization for heart failure (HF). Levels of IGFBP-1 were measured three months after AMI in a stable metabolic phase in 853 patients. For 1106 control subjects, the time of measurement was as close as possible to that of 'his/her' case. Established cardiovascular risk and prognostic factors were also determined. RESULTS: Higher IGFBP-1 values predicted hospitalization for HF during follow-up both in the patient and the control cohort. Control subjects with higher IGFBP-1 values had elevated mortality when compared to those with the lowest quartile. The associations between IGFBP-1 and other outcomes investigated in this study, i.e. mortality among patients, AMI or stroke among patients and controls were weak and statistically not significant. CONCLUSIONS: Levels of IGFBP-1 consistently predicted HF both among survivors of a first AMI and their matched controls. Our results suggest that IGFBP-1 levels might also predict mortality in a population free of previous AMI.
Authors: Robert E Birdsall; Michael P Kiley; Zaneer M Segu; Christopher D Palmer; Milan Madera; Brooks B Gump; James A MacKenzie; Patrick J Parsons; Yehia Mechref; Milos V Novotny; Kestutis G Bendinskas Journal: J Proteome Res Date: 2010-09-03 Impact factor: 4.466
Authors: Marcello Maggio; Chiara Cattabiani; Fulvio Lauretani; Stefania Bandinelli; Francesca De Vita; Elisabetta Dall'Aglio; Andrea Corsonello; Fabrizia Lattanzio; Giuseppe Paolisso; Luigi Ferrucci; Gian Paolo Ceda Journal: J Gerontol A Biol Sci Med Sci Date: 2013-05-13 Impact factor: 6.053
Authors: Adil Rajwani; Vivienne Ezzat; Jessica Smith; Nadira Y Yuldasheva; Edward R Duncan; Matthew Gage; Richard M Cubbon; Matthew B Kahn; Helen Imrie; Afroze Abbas; Hema Viswambharan; Amir Aziz; Piruthivi Sukumar; Antonio Vidal-Puig; Jaswinder K Sethi; Shouhong Xuan; Ajay M Shah; Peter J Grant; Karen E Porter; Mark T Kearney; Stephen B Wheatcroft Journal: Diabetes Date: 2012-02-22 Impact factor: 9.461
Authors: Rita Schüler; Mariya Markova; Martin A Osterhoff; Ayman Arafat; Olga Pivovarova; Jürgen Machann; Johannes Hierholzer; Silke Hornemann; Sascha Rohn; Andreas F H Pfeiffer Journal: Eur J Nutr Date: 2021-03-08 Impact factor: 5.614